본문 바로가기
KERD
논문KCI 등재

Clinical significance of occult hepatitis B virus infection in chronic hepatitis C patients

2

조회

0

다운로드

4

인용

0

참고문헌

키워드

초록

Background/Aims: We investigated the frequency of occult hepatitis B virus (HBV) infection in anti-hepatitis C virus (HCV)-positive individuals and the effects of occult HBV infection on the severity of liver disease. Methods: Seventy-one hepatitis B virus surface-antigen (HBsAg)-negative patients were divided according to their HBV serological status into groups A (anti-HBc positive, anti-HBs negative; n=18), B (anti-HBc positive, anti-HBs positive; n=34), and C (anti-HBc negative, anti-HBs positive/negative; n=19), and by anti-HCV positivity (anti-HCV positive; n=32 vs. anti-HCV negative; n=39). Liver biopsy samples were taken, and HBV DNA was quantified by real-time PCR. Results: Intrahepatic HBV DNA was detected in 32.4% (23/71) of the entire cohort, and HBV DNA levels were invariably low in the different groups. Occult HBV infection was detected more frequently in the anti-HBc-positive patients. Intrahepatic HBV DNA was detected in 28.1% (9/32) of the anti-HCV-positive and 35.9% (14/39) of the anti-HCV-negative subjects. The HCV genotype did not affect the detection rate of intrahepatic HBV DNA. In anti-HCV-positive cases, occult HBV infection did not affect liver disease severity. Conclusions: Low levels of intrahepatic HBV DNA were detected frequently in both HBsAg-negative and anti-HCV-positive cases. However, the frequency of occult HBV infection was not affected by the presence of hepatitis C, and occult HBV infection did not have a significant effect on the disease severity of hepatitis C.

Abstract

Background/Aims: We investigated the frequency of occult hepatitis B virus (HBV) infection in anti-hepatitis C virus (HCV)-positive individuals and the effects of occult HBV infection on the severity of liver disease. Methods: Seventy-one hepatitis B virus surface-antigen (HBsAg)-negative patients were divided according to their HBV serological status into groups A (anti-HBc positive, anti-HBs negative; n=18), B (anti-HBc positive, anti-HBs positive; n=34), and C (anti-HBc negative, anti-HBs positive/negative; n=19), and by anti-HCV positivity (anti-HCV positive; n=32 vs. anti-HCV negative; n=39). Liver biopsy samples were taken, and HBV DNA was quantified by real-time PCR. Results: Intrahepatic HBV DNA was detected in 32.4% (23/71) of the entire cohort, and HBV DNA levels were invariably low in the different groups. Occult HBV infection was detected more frequently in the anti-HBc-positive patients. Intrahepatic HBV DNA was detected in 28.1% (9/32) of the anti-HCV-positive and 35.9% (14/39) of the anti-HCV-negative subjects. The HCV genotype did not affect the detection rate of intrahepatic HBV DNA. In anti-HCV-positive cases, occult HBV infection did not affect liver disease severity. Conclusions: Low levels of intrahepatic HBV DNA were detected frequently in both HBsAg-negative and anti-HCV-positive cases. However, the frequency of occult HBV infection was not affected by the presence of hepatitis C, and occult HBV infection did not have a significant effect on the disease severity of hepatitis C.

참고문헌 (32)

  1. Mason A, "Hepatitis B virus DNA in peripheral-blood mononuclear cells in chronic hepatitis B after HBsAg clearance", Hepatology, 16, pp.36~41 (1992)
  2. Raimondo G, "Squadrito G. Occult hepatitis B virus infection", J Hepatol, 46, pp.160~170 (2007)
  3. Noborg U, "Levels of viraemia in subjects with serological markers of past or chronic hepatitis B virus infection", Scand J Infect Dis, 32, pp.249~252 (2000)
  4. Paterlini P, "Selective accumulation of the X transcript of hepatitis B virus in patients negative for hepatitis B surface antigen with hepatocellular carcinoma", Hepatology, 21, pp.313~321 (1995)
  5. Cacciola I, "Quantification of intrahepatic hepatitis B virus (HBV) DNA in patients with chronic HBV infection", Hepatology, 31, pp.507~512 (2000)
  6. Allain JP, "Occult hepatitis B virus infection: implications in transfusion", Vox Sang, 86, pp.83~91 (2004)
  7. Bréchot C, "Persistent hepatitis B virus infection in subjects without hepatitis B surface antigen: clinically significant or purely "occult"", Hepatology, 34, pp.194~203 (2001)
  8. Hu KQ, "Occult hepatitis B virus infection and its clinical implications", J Viral Hepat, 9, pp.243~257 (2002)
  9. Torbenson M, "Occult hepatitis B", Lancet Infect Dis, 2, pp.479~486 (2002)
  10. Sagnelli E, "Diagnosis and clinical impact of occult hepatitis B infection in patients with biopsy proven chronic hepatitis C: a multicenter study", J Med Virol, 80, pp.1547~1553 (2008)
  11. Yotsuyanagi H, "Persistent viremia after recovery from self-limited acute hepatitis B", Hepatology, 27, pp.1377~1382 (1998)
  12. Bläckberg J, "Occult hepatitis B virus after acute self-limited infection persisting for 30 years without sequence variation", J Hepatol, 33, pp.992~997 (2000)
  13. Rehermann B, "The hepatitis B virus persists for decades after patients' recovery from acute viral hepatitis despite active maintenance of a cytotoxic T-lymphocyte response", Nat Med, 2, pp.1104~1108 (1996)
  14. Liaw YF, "Incidence, determinants and significance of delayed clearance of serum HBsAg in chronic hepatitis B virus infection: a prospective study", Hepatology, 13, pp.627~631 (1991)
  15. Loriot MA, "Persistence of hepatitis B virus DNA in serum and liver from patients with chronic hepatitis B after loss of HBsAg", J Hepatol, 27, pp.251~258 (1997)
  16. Scheuer PJ, "Classification of chronic viral hepatitis: a need for reassessment", J Hepatol, 13, pp.372~374 (1991)
  17. Conjeevaram HS, "Occult hepatitis B virus infection: a hidden menace", Hepatology, 34, pp.204~206 (2001)
  18. Song EY, "Prevalence of Occult Hepatitis B Virus Infection in a General Adult Population in Korea", INTERVIROLOGY, 52, pp.57~62 (2009), KARGER
  19. Kang SY, "The prevalence of "anti-HBc alone" and HBV DNA detection among anti-HBc alone in Korea", J Med Virol, 82, pp.1508~1514 (2010)
  20. Chemin I, "High incidence of hepatitis B infections among chronic hepatitis cases of unknown aetiology", J Hepatol, 34, pp.447~454 (2001)
  21. Cacciola I, "Occult hepatitis B virus infection in patients with chronic hepatitis C liver disease", N Engl J Med, 341, pp.22~26 (1999)
  22. Sagnelli E, "HCV genotype and "silent" HBV coinfection: two main risk factors for a more severe liver disease", J Med Virol, 64, pp.350~355 (2001)
  23. Mariscal LF, "Hepatitis B infection of the liver in chronic hepatitis C without detectable hepatitis B virus DNA in serum", J Med Virol, 73, pp.177~186 (2004)
  24. Fukuda R, "Serologically silent hepatitis B virus coinfection in patients with hepatitis C virus-associated chronic liver disease: clinical and virological significance", J Med Virol, 58, pp.201~207 (1999)
  25. Koike K, "Hepatitis B virus DNA is frequently found in liver biopsy samples from hepatitis C virus-infected chronic hepatitis patients", J Med Virol, 54, pp.249~255 (1998)
  26. Uchida T, "Hepatitis C virus is frequently coinfected with serum marker-negative hepatitis B virus: probable replication promotion of the former by the latter as demonstrated by in vitro cotransfection", J Med Virol, 52, pp.399~405 (1997)
  27. Koike K, "Hepatitis B virus DNA integration frequently observed in the hepatocellular carcinoma DNA of hepatitis C virus-infected patients", Int J Oncol, 8, pp.781~784 (1996)
  28. Kim JH, "The prevalence of HBsAg and anti - HCV in Korean patients with hepatocellular carcinoma", Korean J Med, 46, pp.181~190 (1994)
  29. Kazemi-Shirazi L, "Hepatitis B virus DNA in sera and liver tissue of HBsAg negative patients with chronic hepatitis C", J Hepatol, 33, pp.785~790 (2000)
  30. Mariscal LF, "Hepatitis B infection of the liver in chronic hepatitis C without detectable hepatitis B virus DNA in serum", J Med Virol, 73, pp.177~186 (2004)
  31. Prieto M, "De novo hepatitis B after liver transplantation from hepatitis B core antibody-positive donors in an area with high prevalence of anti-HBc positivity in the donor population", Liver Transpl, 7, pp.51~58 (2001)
  32. Lok AS, "Occult hepatitis B virus infection: diagnosis, implications and management", J Gastroenterol Hepatol, 19, pp.114~117 (2004)

관련 논문AI추천

Clinical features and treatment efficacy of peginterferon alfa plus ribavirin in chronic hepatitis C patients coinfected with hepatitis B virus김보현, 김연수, 김영석, 김유진, 박상훈, 박충기, 이진우, 이천균, 임형준, 정숙향대한간학회 · Clinical and Molecular Hepatology2011 · 제17권 제3호HBsAg 음성인 간질환 환자에서 간조직내 HBV DNA의 검출김부성, 김연수, 김영석, 문종호, 심찬섭, 은수훈, 장재영, 조영덕, 진소영, 천영국대한간학회 · Clinical and Molecular Hepatology2006 · 제12권 제2호Performance of Hepatitis B Core-Related Antigen Versus Hepatitis B Surface Antigen and Hepatitis B Virus DNA in Predicting HBeAg-positive and HBeAg-negative Chronic HepatitisBi-sheng Shi,, Dan Huang,, Dan-ping Liu,, Rong-rong Ding,, Wei Lu,, Xiao-nan Zhang,, Xin-lan Zhou,, Xiu-fen Li,, Yan-bing Wang,, Zhan-qing Zhang대한진단검사의학회 · Annals of Laboratory Medicine2019 · 제39권 제1호Occult HBV among Anti-HBc Alone: Mutation Analysis of an HBV Surface Gene and Pre-S Gene강소영, 김명희, 이우인연세대학교의과대학 · Yonsei Medical Journal2017 · 제58권 제3호Hepatitis B Surface Antigen Quantification across Different Phases of Chronic Hepatitis B Virus Infection Using an Immunoradiometric Assay김원, 김병관, 김지원, 김휘영, 서지연, 이국래, 이호영, 정광현, 정용진, 정지봉, 조유리, 진은효거트앤리버 소화기연관학회협의회 · Gut and Liver2015 · 제9권 제5호Hepatitis B Core Antigen Expression in Hepatocytes Reflects Viral Response to Entecavir in Chronic Hepatitis B Patients김광일, 김대영, 손명수, 유정환, 이정길, 임규성, 황성규, Harry Yoon거트앤리버 소화기연관학회협의회 · Gut and Liver2013 · 제7권 제4호

이 간행물의 다른 논문 (8건)